PHARMACY

Sam’s Club starts new year with new health services

BY DSN STAFF

BENTONVILLE, Ark. — Sam’s Club announced that it is offering its business, advantage and plus members tools to help them achieve their health goals, including free monthly, in-club health screenings and access to a new health management benefit, The Prevention Plan, from U.S. Preventive Medicine.

Sam’s Club said it now is offering The Prevention Plan at $99 for its members. The program involves an online health assessment and at-home blood test to identify potential health issues for which a personalized plan is developed to address risks. Personal health coaching, ongoing support, a variety of tools and a plan-wide health challenge are provided through The Prevention Plan to keep members motivated to maintain a healthy lifestyle, the company reported.

"Through our member insights, we know our members want to stay in control of their health," said Jill Turner-Mitchael, Sam’s Club SVP health and wellness. "We’re proud to offer these simple health solutions, including free health screenings, along with great products like The Prevention Plan so our members can maintain control of their health decisions, minimize health risks and keep healthcare costs low for their families, employees and themselves."

keyboard_arrow_downCOMMENTS

Leave a Reply

L.TROY says:
Dec-05-2012 04:43 am

That is a great news. Now more people will be able to stay fit using these services. All thanks to Sam. Live Discussions

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Inomax’s market exclusivity gets extended

BY Alaric DeArment

CLINTON, N.J. — The Food and Drug Administration has extended by six months the market exclusivity of a lung disease drug for use in children.

Drug maker Ikaria said Wednesday that the FDA had extended pediatric exclusivity period for the drug Inomax (nitric oxide) from January 2013 to July 2013.

Ikaria said the extension was based on results of a clinical study of the drug in preterm infants with bronchopulmonary dysplasia, a serious condition that results from lung injury.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Report: Sharfstein to leave FDA

BY Alaric DeArment

SILVER SPRING, Md. — Food and Drug Administration principal deputy commissioner Joshua Sharfstein will leave the agency to become head of the Maryland Department of Health and Mental Hygiene, according to published reports.

The Washington Post reported Wednesday that Sharfstein, the FDA’s top official after commissioner Margaret Hamburg, had received an invitation to head the state health department from Gov. Martin O’Malley.

Before assuming his position at the FDA, Sharfstein served as head of the Baltimore City Health Department.

It was in that capacity that Sharfstein filed a Citizen’s Petition to restrict the recommendation of pediatric cough-cold medicines to children older than age 6 years. More recently, Sharfstein stood alongside Council for Responsible Nutrition president and CEO Steve Mister and other supplement industry representatives in announcing a crack-down on those Internet companies distributing adulterated pharmaceutical products marketed as dietary supplements.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?